RecruitingNCT06814925
Italian Study of Patients With Lymphoma
Italian Prospective Observational Cohort Study of Patients With Lymphoma
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Enrollment
1,500 participants
Start Date
Dec 7, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
It is an observational, non-interventional, prospective, monocentric study, whose objective is to enroll 1500 patients with lymphoma in 5 years within the Institute of Hematology "Seragnoli".
Eligibility
Min Age: 18 Years
Inclusion Criteria4
- Age greater than or equal to 18 years at enrollment
- Diagnosis of lymphoma within 3 months of enrollment
- Patients may have been treated, as long as the initial diagnosis of lymphoma is within 3 months of enrollment
- Signing of the informed consent form
Exclusion Criteria1
- none
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06814925
Related Trials
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
NCT0685942413 locations
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
NCT0233266817 locations
Odronextamab in Low Tumor Volume Advanced FL
NCT071286411 location
Dietary and Topical Magnesium Replacement or Supplementation in Patients With Lymphoma
NCT052943671 location
Rituximab Plus Venetoclax in Front Line Marginal Zone Lymphoma
NCT065103091 location